News Releases

Press Releases

  • 9/18/17 7:30 am EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 at 10:55 a.m. Eastern time. Dr. Aklog will provide a corporate overview, discuss the Company’s innovative business model and review PAVmed’s lead products. Themore...
  • 8/14/17 7:30 am EDT

    Conference call to be held August 17, 2017 at 4:30 p.m. Eastern time

    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three and six months ended June 30, 2017 and provided a business update. “During this past quarter and in recent weeks PAVmed has continued to grow stronger as a company, moving steadily towards major developmental, regulatory and commercialization milestones, while exploring all opportunitiesmore...
  • 8/9/17 7:30 am EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on Thursday, August 17, 2017 at 4:30 p.m. Eastern time. During this call Lishan Aklog, M.D., the Company’s Chairman and Chief Executive Officer, will provide a business update including an overview of the Company’s near-term milestones and growth strategy. In addition, Dennis McGrath, themore...
  • 7/5/17 7:30 am EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of a $5 million financing provided by Scopia Holdings LLC. The private placement offering consisted of $5 million in senior secured notes as well as Series S warrants. The net proceeds of the transaction will be used for the company’s working capital needs and advancement of its lead products. “Thismore...
  • 6/23/17 4:51 pm EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that on June 23, 2017, the Securities and Exchange Commission declared effective PAVmed’s registration statement on Form S-1 relating to resale by certain selling securityholders of certain shares and warrants issued and issuable from the Company’s previously announced preferred unit offering. PAVmed registered these securities tomore...
  • 6/22/17 4:01 pm EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that the Company will join the Russell Microcap® Index at the conclusion of the Russell Indexes’ annual reconstitution, effective after the U.S. market opens on June 26, 2017, according to a preliminary list of additions posted June 9, 2017 and again on June 16, 2017. Membership in the Russell Microcap® Index providesmore...
  • 5/22/17 4:05 pm EDT

    Conference call to be held May 31, 2017 at 4:30 p.m. Eastern time

    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three months ended March 31, 2017 and provided a business update. “During the first quarter we continued to make solid progress in advancing our growth strategy and multiproduct pipeline towards commercialization, utilizing our capital- and time-efficient business model,” said Lishan Aklog, M.D.,more...
  • 5/16/17 4:35 pm EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (NASDAQ:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will postpone its business update conference call to May 31, 2017 at 4:30 p.m. Eastern time. The call had originally been set for May 17, 2017 at 4:30 p.m. Eastern time. Lishan Aklog, M.D., the Company’s Chairman and Chief Executive Officer, and Brian de Guzman, M.D., the Company’s Chief Medical Officer, willmore...
  • 5/10/17 8:30 am EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on May 17, 2017 at 4:30 p.m. Eastern time. During this call Lishan Aklog, M.D., the Company’s Chairman and Chief Executive Officer, and Brian de Guzman, M.D., the Company’s Chief Medical Officer, will provide a business update including an overview of the Company’s near-term milestones andmore...
  • 4/10/17 4:52 pm EDT

    Exchange Structured to Reward Current Security Holders and Incentivize Long-term Ownership by Both Existing and New Investors

    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it filed a registration statement on Form S-4 with the Securities and Exchange Commission relating to the Company’s previously announced intention to effectuate a registered exchange offer (the “Exchange”) whereby PAVmed’s Common Stock will become exchangeable for units (the “New Units”). Pursuant to the Exchange, eachmore...

SEC Filings

Click Here to view PAVmed's SEC filings

INVESTOR PRESENTATION

Click Here to view PAVmed’s current Investor Presentation

PROXY MATERIALS

Click Here to view the Proxy Statement for PAVmed Inc 2017 Annual Meeting

Click Here view the Annual Report for PAVmed Inc 2017 Annual Meeting